Bredesen-Informed Brain Health: What Practitioners Need to Know

The work of Dr Dale Bredesen — neurologist, researcher, and author of The End of Alzheimer's — has been one of the most significant developments in the field of cognitive decline prevention in recent decades. His ReCODE (Reversal of Cognitive Decline) protocol, and the subsequent ReCODE 2.0 framework, represent a fundamental shift in how cognitive decline is understood and approached: not as a single-cause disease requiring a single intervention, but as a multi-factor syndrome requiring a personalised, systems-based response.

For natural health practitioners, the Bredesen framework is highly relevant — not because it provides a simple protocol to follow, but because it offers a structured way of thinking about cognitive presentations that aligns well with the functional medicine and nutritional medicine approach to complex chronic health conditions.

The Core Premise: Cognitive Decline as a Multi-Factor Syndrome

Bredesen's central argument is that Alzheimer's disease and cognitive decline are not caused by a single pathological process — such as amyloid accumulation — but by a network of interacting contributors that collectively overwhelm the brain's capacity to maintain and repair itself. He identifies multiple "subtypes" of Alzheimer's disease based on the dominant contributing factors, including inflammatory, atrophic, toxic, vascular, and glycotoxic subtypes.

This framework has significant clinical implications. It means that a patient with predominantly inflammatory drivers requires a different intervention strategy than a patient with predominantly metabolic or toxic drivers. And it means that a single-intervention approach — whether pharmaceutical or nutritional — is unlikely to be sufficient for most patients.

The ReCODE Framework: Key Domains

Inflammation and immune activation

Chronic neuroinflammation is a central feature of Alzheimer's pathophysiology. The ReCODE framework assesses inflammatory markers including hsCRP, homocysteine, and relevant immune markers, and addresses inflammatory drivers through diet, gut health, infection management, and targeted supplementation.

Metabolic health and insulin signalling

Insulin resistance — and the impaired brain glucose metabolism that accompanies it — is one of the most significant modifiable contributors to cognitive decline in the ReCODE framework. Assessment includes fasting insulin, HbA1c, and metabolic markers, with intervention focused on dietary modification, movement, and metabolic support.

Hormonal and trophic support

The brain requires adequate trophic support — including BDNF (brain-derived neurotrophic factor), oestrogen, testosterone, thyroid hormones, and other growth factors — to maintain synaptic density and neuroplasticity. The ReCODE framework assesses and addresses hormonal deficiencies as a component of cognitive support.

Toxic exposures

Environmental toxins — including heavy metals, mycotoxins (from mould exposure), organic pollutants, and other toxic loads — can contribute to neuroinflammation and cognitive impairment. The ReCODE framework includes toxin assessment and, where relevant, detoxification support as a component of the protocol.

Vascular health

Cerebrovascular health — including blood pressure management, homocysteine reduction, and omega-3 support for vascular integrity — is a component of the ReCODE framework, reflecting the significant overlap between vascular dementia and Alzheimer's disease.

Sleep and circadian rhythm

Sleep is explicitly included in the ReCODE framework as a foundational component of cognitive health — reflecting the importance of glymphatic clearance and the well-established relationship between sleep disruption and dementia risk.

"The Bredesen framework does not provide a protocol to follow — it provides a way of thinking. That is what makes it genuinely useful in clinical practice."

What ReCODE 2.0 Certification Involves

ReCODE 2.0 certification is a structured training programme for health practitioners that covers the theoretical foundations of the Bredesen framework, the clinical assessment tools used in the protocol, and the application of personalised intervention strategies. Jo Grabyn is a ReCODE 2.0 Certified Practitioner — one of a relatively small number in Australia — and incorporates Bredesen-informed principles into her ClearPath Method framework.

For practitioners interested in working more effectively with cognitive decline presentations, understanding the Bredesen framework — even without formal certification — provides a valuable clinical lens. The ClearPath Method practitioner training incorporates Bredesen-informed principles alongside Jo's own clinical reasoning framework for brain-health presentations.

Scope and Limitations

It is important to note that the Bredesen framework is not a cure for Alzheimer's disease, and the published evidence base — while promising — consists primarily of case series and small studies rather than large randomised controlled trials. The framework is best understood as a structured, evidence-informed approach to prevention and early intervention, not a treatment for established dementia.

For natural health practitioners, the most appropriate application is in prevention-focused work with patients who have risk factors, early symptoms, or family history concerns — and in collaborative care alongside appropriate medical management for patients with established diagnoses.